Acerus Pharmaceuticals OTC Stock Forecast - Polynomial Regression
| ASPCFDelisted Stock | USD 0.22 0.00 0.00% |
The Polynomial Regression forecasted value of Acerus Pharmaceuticals on the next trading day is expected to be 0.18 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.91. Acerus OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Acerus Pharmaceuticals stock prices and determine the direction of Acerus Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Acerus Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Acerus |
Most investors in Acerus Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Acerus Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Acerus Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Acerus Pharmaceuticals polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Acerus Pharmaceuticals as well as the accuracy indicators are determined from the period prices. Acerus Pharmaceuticals Polynomial Regression Price Forecast For the 26th of April
Given 90 days horizon, the Polynomial Regression forecasted value of Acerus Pharmaceuticals on the next trading day is expected to be 0.18 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.91.Please note that although there have been many attempts to predict Acerus OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Acerus Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Acerus Pharmaceuticals OTC Stock Forecast Pattern
| Backtest Acerus Pharmaceuticals | Acerus Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Acerus Pharmaceuticals otc stock data series using in forecasting. Note that when a statistical model is used to represent Acerus Pharmaceuticals otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.9371 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0313 |
| MAPE | Mean absolute percentage error | 0.096 |
| SAE | Sum of the absolute errors | 1.9094 |
Predictive Modules for Acerus Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acerus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acerus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acerus Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acerus Pharmaceuticals otc stock to make a market-neutral strategy. Peer analysis of Acerus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acerus Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Acerus Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Acerus Pharmaceuticals otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acerus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Acerus Pharmaceuticals otc stock market strength indicators, traders can identify Acerus Pharmaceuticals entry and exit signals to maximize returns.
Acerus Pharmaceuticals Risk Indicators
The analysis of Acerus Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Acerus Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting acerus otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.14 | |||
| Standard Deviation | 7.63 | |||
| Variance | 58.15 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Acerus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acerus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acerus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Acerus OTC Stock
| 0.84 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.48 | TPDDF | Talon Energy | PairCorr |
| 0.47 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.47 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.45 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to Acerus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acerus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acerus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acerus Pharmaceuticals to buy it.
The correlation of Acerus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acerus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acerus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acerus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Acerus Pharmaceuticals information on this page should be used as a complementary analysis to other Acerus Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Acerus OTC Stock
If you are still planning to invest in Acerus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acerus Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |